<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:chebi fb="21" ids="16136">Hydrogen sulphide</z:chebi> is a recently identified endogenous endothelium-dependent <z:chebi fb="1" ids="35620">vasodilator</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Animal models of <z:mp ids='MP_0002055'>diabetes</z:mp> have shown that low plasma H(2)S levels are associated with marked <z:e sem="disease" ids="C0856169" disease_type="Disease or Syndrome" abbrv="">endothelial dysfunction</z:e> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>However, human studies on H(2)S and vascular function in health and disease are lacking </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Plasma was obtained from male patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 11), overweight (n = 16) and lean (n = 11) volunteers </plain></SENT>
<SENT sid="4" pm="."><plain>H(2)S levels were determined by zinc trap spectrophotometry </plain></SENT>
<SENT sid="5" pm="."><plain>Anthropometric measurements (BMI/waist:hip ratio), <z:chebi fb="23" ids="18059">lipid</z:chebi> profile, systemic blood pressure, biochemical indices of <z:mp ids='MP_0002055'>diabetes</z:mp> (fasting <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin sensitivity, Hb(1Ac)) and microvascular function (minimum vascular resistance) were determined </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Median plasma H(2)S levels (25th, 75th percentiles) in age-matched lean, overweight and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> individuals were 38.9 (29.7, 45.1) micromol/l, 22.0 (18.6, 26.7) micromol/l and 10.5 (4.8, 22.0) micromol/l, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Median plasma H(2)S levels were significantly lower in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> compared with lean (p = 0.001, Mann-Whitney) and overweight participants (p = 0.008) </plain></SENT>
<SENT sid="8" pm="."><plain>Median plasma H(2)S levels in overweight participants were significantly lower than in lean controls (p = 0.003) </plain></SENT>
<SENT sid="9" pm="."><plain>Waist circumference was an independent predictor of plasma H(2)S (R (2) = 0.423, standardised beta: -0.650, p &lt; 0.001) </plain></SENT>
<SENT sid="10" pm="."><plain>This relationship was independent of <z:mp ids='MP_0002055'>diabetes</z:mp>, which only contributed a further 5% to the model (R (2) = 0.477) </plain></SENT>
<SENT sid="11" pm="."><plain>Waist circumference or other measures of <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> (waist:hip ratio/BMI) remained independent predictors of plasma H(2)S after adjustment for systolic blood pressure, microvascular function, insulin sensitivity, glycaemic control and <z:chebi fb="23" ids="18059">lipid</z:chebi> profile </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS/INTERPRETATION: Plasma H(2)S levels are reduced in overweight participants and patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="13" pm="."><plain>Increasing <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> is a major determinant of plasma H(2)S levels </plain></SENT>
</text></document>